Erektil dysfunktion og metabolisk syndrom
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 306 KB, PDF-dokument
This review covers erectile dysfunction (ED) in men with metabolic syndrome. Men suffering from metabolic syndrome, and all its components, are at increased risk of ED. Men with ED should be metabolically screened with BMI, waist circumference, blood pressure, HbA1c and lipids. Components of the metabolic syndrome should be well-controlled as first step in treating ED using lifestyle changes and pharmaceutical therapies. Symptomatic treatments include phosphodiesterase type 5 inhibitors, penile injections, intraurethral medication, vacuum pumps and penile implants.
Bidragets oversatte titel | Erectile dysfunction and metabolic syndrome |
---|---|
Originalsprog | Dansk |
Artikelnummer | V03220227 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 184 |
Udgave nummer | 42 |
Antal sider | 8 |
ISSN | 0041-5782 |
Status | Udgivet - 17 okt. 2022 |
- Male, Humans, Erectile Dysfunction/drug therapy, Metabolic Syndrome/complications, Penile Prosthesis/adverse effects, Phosphodiesterase 5 Inhibitors/therapeutic use
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-10/v03220227_web.pdf
Forlagets udgivne version
ID: 325841077